The Molecular Cartography™ Company

We are bringing the latest advances in German precision engineering to the biotechnology field.

Together with our talented team of scientists and investors, we are poised to lead the next generation of single-cell analysis, which will enable scientists around the world the opportunity to apply the power of Molecular Cartography to their research, and gain new insights based on the highest-resolution view of single-cell spatial biology. Resolve Biosciences is privately held and headquartered in Monheim am Rhein, Germany.

01 — Investors

Investors

The $24 million Series A financing round was led by PS Capital Management and MasterMind Advisory Services and included participation from Alafi Capital, John Shoffner, and High Tech Gründerfonds.

The $71 million Series B financing was the latest round of funding led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors. The company has now raised more than $100 million.

 Board of Directors 

02 — Board of Directors

Board of Directors

John Stark

John Stark

Peer M. Schatz

Peer M. Schatz

Axel Heinemann

Axel Heinemann

Laura Furmanski

Laura Furmanski

Aristotelis Nastos

Aristotelis Nastos

Christopher Alafi

Christopher Alafi

 Management Team 

03 — Management Team

Management Team

John Stark

John Stark

Chief Executive Officer

Kieren Patel

Kieren Patel

Chief Business Officer

Meike Bongers

Meike Bongers

Head of Human Resources


Frank Zhong

Frank Zhong

Chief Technology Officer

Oliver Dick

Oliver Dick

Chief Operations Officer

 The Offices 

05 — Do you want to join us?

Do you want to join us?

This is the perfect opportunity for a successful candidate to become a part of a highly motivated, agile, and international team in an attractive work environment with excellent career opportunities and flat hierarchies.

You will contribute to develop our cutting-edge technology with the clear goal to offer products worldwide, and you will influence both our products and clients. We provide space for creativity and flexible working hours and look forward for new members to join us on an exciting journey into a new field of biotechnology. Still in the start-up phase, we wish to collaborate and grow together with forward-minded people.

Join us

⌃
Image of

Close